These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
104 related articles for article (PubMed ID: 491366)
1. [Use of visken and hyperstat in hypertensive crisis]. Gorbacgenkov AA; Savenkov PM; Klevtsova MN; Ozherel'eva NI; Albegov AS Kardiologiia; 1979 Aug; 19(8):95-9. PubMed ID: 491366 [TBL] [Abstract][Full Text] [Related]
2. [Use of Visken-15 for treating hypertension]. Erina EV; Megrelishvili RI; Pushkar' IuT; Beliakova EV; Lediashova GA Kardiologiia; 1979 Mar; 19(3):46-52. PubMed ID: 372668 [TBL] [Abstract][Full Text] [Related]
3. [Use of Hyperstat for arresting hypertensive crises]. Golikov AP; Babkov VK; Borisenko AP; Ivleva VI Kardiologiia; 1978 Nov; 18(11):96-102. PubMed ID: 364167 [TBL] [Abstract][Full Text] [Related]
4. [Treatment of hypertension with a new beta-adrenergic blocking agent, pindolol (Viskén)]. Persson I; Ulrich J Ugeskr Laeger; 1973 May; 135(20):968-70. PubMed ID: 4755952 [No Abstract] [Full Text] [Related]
5. [Use of the adrenergic beta receptor blockader, visken, (prindolol) in arterial hypertension]. Savenkov PM; Doshitsin VL; Grudtsyn GV Kardiologiia; 1977 Oct; 17(10):62-6. PubMed ID: 599799 [TBL] [Abstract][Full Text] [Related]
6. [Use of beta-adrenergic blockaders in the treatment of arterial hypertension]. Erina EV; Basishvili NZ Kardiologiia; 1978 Mar; 18(3):28-35. PubMed ID: 25351 [TBL] [Abstract][Full Text] [Related]
7. [Effect of pindolol (Visken) on blood pressure and plasma renin activity in various forms of hypertension]. Werning C; Vetter H Adv Clin Pharmacol; 1976; 11():54-60. PubMed ID: 1032571 [TBL] [Abstract][Full Text] [Related]
8. Combined intravenous administration of diazoxide and beta-blocking agent in acute treatment of severe hypertension or hypertensive crisis. Huysmans FT; Thien TA; Koene RA Am Heart J; 1982 Mar; 103(3):395-400. PubMed ID: 6121478 [TBL] [Abstract][Full Text] [Related]
10. [The antihypertensive action of the beta adrenergic blocking agent Visken (pindolol, LB 46) in mild and moderate hypertension]. Török E; Jávor T; Szám I; Gábor G Orv Hetil; 1976 Mar; 117(10):593-8. PubMed ID: 1250586 [No Abstract] [Full Text] [Related]
11. Adrenergic beta-receptor blockade in essential hypertension: a comparison between pindolol (Visken) and propranolol (Inderal). Bjerle P; Jacobsson KA; Agert G Curr Ther Res Clin Exp; 1975 Sep; 18(3):387-94. PubMed ID: 241607 [No Abstract] [Full Text] [Related]
13. The antihypertensive effect of pindolol (Visken) alone and combined with clopamide (Brinaldix). Persson I Eur J Clin Pharmacol; 1977 Jul; 11(6):419-21. PubMed ID: 330169 [TBL] [Abstract][Full Text] [Related]
14. Effect of the beta-receptor blocking agent visken on blood pressure of hypertensive patients, on plasma renin activity and electrolytes. Sonkodi S; Pap A; Varró V Ther Hung; 1976; 24(2):60-2. PubMed ID: 982340 [No Abstract] [Full Text] [Related]
15. [Ambulatory treatment of so-called "essential" arterial hypertension with pindolol. Short-term study]. Reffo GC; Pitzorno G; Perin S; Forattini C Minerva Med; 1980 Jan; 71(1):49-54. PubMed ID: 6101911 [TBL] [Abstract][Full Text] [Related]
16. Blood pressure reactivity in the evaluation of resting blood pressure and mood responses to pindolol and propranolol in hypertensive patients. Potempa KM; Fogg LF; Fish AF; Kravitz HM Heart Lung; 1993; 22(5):383-91. PubMed ID: 8226001 [TBL] [Abstract][Full Text] [Related]
17. Combination therapy of essential hypertension with pindolol (Visken) and hydralazine. Persson I Eur J Clin Pharmacol; 1975 Dec; 9(2-3):91-3. PubMed ID: 786690 [TBL] [Abstract][Full Text] [Related]
18. Intravenous diazoxide therapy in hypertensive crisis. McDonald WJ; Smith G; Woods JW; Perry HM; Danielson BD Am J Cardiol; 1977 Sep; 40(3):409-15. PubMed ID: 331925 [TBL] [Abstract][Full Text] [Related]
19. The addition of Visken to methyldopa therapy in hypertension: a multicentre study. Murphy JE J Int Med Res; 1976; 4(2):128-31. PubMed ID: 1026542 [TBL] [Abstract][Full Text] [Related]